References
- Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.
- Herbst RS, Morgensztern D, Boshoff C. The biology and management of non-small cell lung cancer. Nature. 2018;553(7689):446–454.
- Evison M, AstraZeneca UKL. The current treatment landscape in the UK for stage III NSCLC. Br J Cancer. 2020;123(Suppl 1):3–9.
- Lane-Donovan C, Herz J. The ApoE receptors Vldlr and Apoer2 in central nervous system function and disease. J Lipid Res. 2017;58(6):1036–1043.
- Kim J, Yoon H, Basak J, et al. Apolipoprotein E in synaptic plasticity and alzheimer’s disease: potential cellular and molecular mechanisms. Mol Cells. 2014;37(11):767–776.
- Yang T, Williams BO. Low-density lipoprotein receptor-related proteins in skeletal development and disease. Physiol Rev. 2017;97(3):1211–1228.
- Hamad MIK, Jbara A, Rabaya O, et al. Reelin signaling modulates GABAB receptor function in the neocortex. J Neurochem. 2021;156(5):589–603.
- Roslan Z, Muhamad M, Selvaratnam L, et al. the roles of low-density lipoprotein receptor-related proteins 5, 6, and 8 in cancer: a review. J Oncol. 2019;2019:4536302.
- Tavazoie MF, Pollack I, Tanqueco R, et al. LXR/ApoE activation restricts innate immune suppression in cancer. Cell. 2018;172(4):825–840 e818.
- Pencheva N, Tran H, Buss C, et al. Convergent multi-miRNA targeting of ApoE drives LRP1/LRP8-dependent melanoma metastasis and angiogenesis. Cell. 2012;151(5):1068–1082.
- Arai T, Kojima S, Yamada Y, et al. Pirin: a potential novel therapeutic target for castration-resistant prostate cancer regulated by miR-455-5p. Mol Oncol. 2019;13(2):322–337.
- Dun B, Sharma A, Teng Y, et al. Mycophenolic acid inhibits migration and invasion of gastric cancer cells via multiple molecular pathways. PLoS One. 2013;8(11):e81702.
- Cai J, Chen J, Wu T, et al. Genome-scale CRISPR activation screening identifies a role of LRP8 in Sorafenib resistance in hepatocellular carcinoma. Biochem Biophys Res Commun. 2020;526(4):1170–1176.
- Du S, Wang H, Cai J, et al. Apolipoprotein E2 modulates cell cycle function to promote proliferation in pancreatic cancer cells via regulation of the c-Myc-p21(Waf1) signalling pathway. Biochem Cell Biol. 2020;98(2):191–202.
- Clevers H, Loh KM, Nusse R. Stem cell signaling. An integral program for tissue renewal and regeneration: wnt signaling and stem cell control. Science. 2014;346(6205):1248012.
- Jeong W, Jho EH. Regulation of the low-density lipoprotein receptor-related protein LRP6 and its association with disease: wnt/beta-Catenin signaling and beyond. Front Cell Dev Biol. 2021;9:714330.
- Becker J, Frohlich J, Perske C, et al. Reelin signalling in neuroblastoma: migratory switch in metastatic stages. Int J Oncol. 2012;41(2):681–689.
- Rapp J, Jaromi L, Kvell K, et al. WNT signaling - lung cancer is no exception. Respir Res. 2017;18(1):167.
- Zhang H, Liu S, Tang L, et al. Long non-coding RNA (LncRNA) MRPL23-AS1 promotes tumor progression and carcinogenesis in osteosarcoma by activating Wnt/beta-catenin signaling via inhibiting microRNA miR-30b and upregulating myosin heavy chain 9 (MYH9). Bioengineered. 2021;12(1):162–171.
- Zhang J, Zhang X, Zhang L, et al. LRP8 mediates Wnt/beta-catenin signaling and controls osteoblast differentiation. J Bone Miner Res. 2012;27(10):2065–2074.
- Lin CC, Lo MC, Moody R, et al. Targeting LRP8 inhibits breast cancer stem cells in triple-negative breast cancer. Cancer Lett. 2018;438:165–173.
- Zhou L, Wang H, and Fang Z, et al. The microRNA-381(miR-381)/Spindlin1(SPIN1) axis contributes to cell proliferation and invasion of colorectal cancer cells by regulating the Wnt/beta-catenin pathway. Bioengineered. 2021 Dec;12(2):12036–12048.
- Zhong M, Zhou L, Zou J, et al. Cullin-4B promotes cell proliferation and invasion through inactivation of p53 signaling pathway in colorectal cancer. Pathol Res Pract. 2021;224:153520.
- Fang Z, Zhong M, Wang Y, et al. miR381 and miR489 suppress cell proliferation and invasion by targeting CUL4B via the Wnt/betacatenin pathway in gastric cancer. Int J Oncol. 2019;54(2):733–743.
- Zhong M, Zhou L, Fang Z, et al. Ubiquitin-specific protease 15 contributes to gastric cancer progression by regulating the Wnt/beta-catenin signaling pathway. World J Gastroenterol. 2021;27(26):4221–4235.
- Coudray N, Ocampo PS, Sakellaropoulos T, et al. Classification and mutation prediction from non-small cell lung cancer histopathology images using deep learning. Nat Med. 2018;24(10):1559–1567.
- Li T, Fu J, Zeng Z, et al. TIMER2.0 for analysis of tumor-infiltrating immune cells. Nucleic Acids Res. 2020;48(W1):W509–W514.
- Chandrashekar DS, Bashel B, Balasubramanya SAH, et al. UALCAN: a portal for facilitating tumor subgroup gene expression and survival analyses. Neoplasia. 2017;19(8):649–658.
- Wang R, Liu J, Li K, et al. An SETD1A/Wnt/beta-catenin feedback loop promotes NSCLC development. J Exp Clin Cancer Res. 2021;40(1):318.
- Liao Y, Feng J, Sun W, et al. CIRP promotes the progression of non-small cell lung cancer through activation of Wnt/beta-catenin signaling via CTNNB1. J Exp Clin Cancer Res. 2021;40(1):275.
- Kureel J, John AA, Prakash R, et al. MiR 376c inhibits osteoblastogenesis by targeting Wnt3 and ARF-GEF-1 -facilitated augmentation of beta-catenin transactivation. J Cell Biochem. 2018;119(4):3293–3303.
- Tang X, Li G, Shi L, et al. Combined intermittent fasting and ERK inhibition enhance the anti-tumor effects of chemotherapy via the GSK3beta-SIRT7 axis. Nat Commun. 2021;12(1):5058.
- Gallagher EJ, Zelenko Z, Neel BA, et al. Elevated tumor LDLR expression accelerates LDL cholesterol-mediated breast cancer growth in mouse models of hyperlipidemia. Oncogene. 2017;36(46):6462–6471.
- Deng D, Zhang Y, Bao W, et al. Low-density lipoprotein receptor-related protein 6 (LRP6) rs10845498 polymorphism is associated with a decreased risk of non-small cell lung cancer. Int J Med Sci. 2014;11(7):685–690.
- Mammoto T, Chen Z, Jiang A, et al. Acceleration of lung regeneration by platelet-rich plasma extract through the low-density lipoprotein receptor-related protein 5-tie2 pathway. Am J Respir Cell Mol Biol. 2016;54(1):103–113.
- Li HJ, Ke FY, Lin CC, et al. ENO1 promotes lung cancer metastasis via HGFR and WNT signaling-driven epithelial-to-mesenchymal transition. Cancer Res. 2021;81(15):4094–4109.
- Qiu H, Shen X, Chen B, et al. miR-30b-5p inhibits cancer progression and enhances cisplatin sensitivity in lung cancer through targeting LRP8. Apoptosis. 2021;26(5–6):261–276.
- Li L, Qu WH, Ma HP, et al. LRP8, modulated by miR-1262, promotes tumour progression and forecasts the prognosis of patients in breast cancer. Arch Physiol Biochem. 2020;1–9.
- Yang S, Liu Y, Li MY, et al. FOXP3 promotes tumor growth and metastasis by activating Wnt/beta-catenin signaling pathway and EMT in non-small cell lung cancer. Mol Cancer. 2017;16(1):124.
- Liu S, Fan W, Gao X, et al. Estrogen receptor alpha regulates the Wnt/beta-catenin signaling pathway in colon cancer by targeting the NOD-like receptors. Cell Signal. 2019;61:86–92.
- Sinha RK, Yang XV, Fernandez JA, et al. Apolipoprotein E receptor 2 mediates activated protein C-induced endothelial Akt activation and endothelial barrier stabilization. Arterioscler Thromb Vasc Biol. 2016;36(3):518–524.
- Sacharidou A, Chambliss KL, Ulrich V, et al. Antiphospholipid antibodies induce thrombosis by PP2A activation via apoER2-Dab2-SHC1 complex formation in endothelium. Blood. 2018;131(19):2097–2110.